Hongbo Lu, Director at Terns Pharmaceuticals, Inc. (TERN), bought 476,190 shares at $10.50 ($5.0M) on 2024-09-12, disclosed to the SEC on 2024-09-17.
Open-market purchase of $5.0M TERN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.50 | 190,476 | $2.0M | 40.0% |
| 2 | $10.50 | 285,714 | $3.0M | 60.0% |
| Total | $10.50 avg | 476,190 | $5.0M | 100% |
| Filing → |
| ZBIO | BUY | 2026-03-31 | $1.5M | — | Filing → |
| ZBIO | BUY | 2026-02-13 | $585K | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |